HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not ...
Reclast is indicated for treatment of osteoporosis in postmenopausal women. In postmenopausal women with osteoporosis, diagnosed by bone mineral density ...
http://www.pharma.us.novartis.com/product/pi/pdf/reclast.pdf...
|
Reclast (zoledronic acid) Injection
10 Jul 2009 ... Monitor serum creatinine before each Reclast dose. Transient increase in serum creatinine may be greater in patients with impaired renal ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...
|
Reclast | Industry information for Reclast
Reclast is indicated for treatment and prevention of osteoporosis in postmenopausal women. In patients with a recent low-trauma hip fracture, ...
http://www.medscape.com/infosite/reclast...
|
Reclast - DailyMed: About DailyMed
These highlights do not include all the information needed to use RECLAST safely and effectively. See full prescribing information for RECLAST. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=9452...
|
Reclast - Discussion - National Osteoporosis Foundation Support ...
I have been reading your posts, I have been advised to take reclast. I am for some reason not sure if I should do this. ...
http://www.inspire.com/groups/national-osteoporosis-foundati...
|
Reclast | Industry information for Reclast
For patients not covered by Medicare, most will be covered by PPO or HMO plans which will provide coverage for Reclast, although coverage may vary by plan. ...
http://www.medscape.com/infosite/reclast/article-5...
|
FDA approves once-yearly Reclast® for osteoporosis in men - Press ...
6 Jan 2009 ... Reclast increased lumbar spine bone mineral density (BMD) in men with ... Once- yearly Reclast is the only osteoporosis treatment approved to ...
http://www.pharma.us.novartis.com/newsroom/press-release.jsp...
|
FDA approves Reclast® to prevent osteoporosis in postmenopausal ...
1 Jun 2009 ... Single infusion of Reclast increases bone mass for two years in postmenopausal women with osteopenia, a condition that can lead to ...
http://www.novartis.com/newsroom/media-releases/en/2009/1318...
|
Once-yearly Reclast® approved by FDA to treat and prevent steroid ...
17 Mar 2009 ... Once-yearly Reclast® approved by FDA to treat and prevent steroid-induced osteoporosis, marking its fourth approved indication.
http://www.pharma.us.novartis.com/newsroom/press-release.jsp...
|
FDA Approvals: Kadian, Depocyt, Reclast
12 Jun 2007 ... The FDA has approved a 10-mg formulation for morphine sulfate extended-release capsules (Kadian), cytarabine liposome injection (Depocyt), ...
http://www.medscape.com/viewarticle/558084...
|
